| Early documentation of therapeutic response at 6 weeks following corticosteroid therapy in extensive sarcoidosis: promise of FDG-PET. | |
| | |
MedLine Citation:
|
PMID: 19893402 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A 52-year-old man, who was treated with antitubercular drugs for 1 year without any benefit for an initial diagnosis of tuberculosis, and was referred for further evaluation. An FDG-PET study was performed to evaluate the whole-body disease status, which showed multiple abnormal foci in bilateral neck nodes, mediastinal, axillary, and multiple abdominal (para-aortic and inguinal) nodes, and the liver, spleen, and thyroid. A rebiopsy of the inguinal nodes for a definitive diagnosis was confirmatory of sarcoidosis. He had a history of hypothyroidism, which is a frequent accompaniment of sarcoidosis due to the association of autoimmunity in this population. He was treated with oral corticosteroids and was referred for reassessment of his disease status with FDG-PET following 6 weeks of therapy. The FDG-PET images showed remarkable improvement with near total resolution of the FDG hypermetabolism at the initially involved sites. The present case underscores the value of FDG-PET imaging in whole-body monitoring of early response to therapy in patients of sarcoidosis (particularly those with extensive disease) that can be of substantial benefit and indicates the promise of this powerful molecular imaging technique in managing this multisystem disorder. |
| | |
Authors:
|
Sandip Basu; Ramesh V Asopa; Nawab S Baghel |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Clinical nuclear medicine Volume: 34 ISSN: 1536-0229 ISO Abbreviation: Clin Nucl Med Publication Date: 2009 Oct |
Date Detail:
|
Created Date: 2009-11-06 Completed Date: 2010-02-01 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7611109 Medline TA: Clin Nucl Med Country: United States |
Other Details:
|
Languages: eng Pagination: 689-90 Citation Subset: IM |
Affiliation:
|
Radiation Medicine Centre (BARC), Tata Memorial Hospital, Parel, Mumbai, India. drsanb@yahoo.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenal Cortex Hormones
/
therapeutic use* Documentation* Fluorodeoxyglucose F18 / diagnostic use* Humans Male Middle Aged Positron-Emission Tomography* Sarcoidosis / drug therapy*, radionuclide imaging* |
| Chemical | |
Reg. No./Substance:
|
0/Adrenal Cortex Hormones; 63503-12-8/Fluorodeoxyglucose F18 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Epstein-Barr virus (EBV) associated lymphoepithelioma-like thymic carcinoma associated with paraneop...
Next Document: FDG uptake in a rheumatoid nodule with imaging appearance similar to a malignant soft tissue tumor.